n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auzeloux, P; Blache, Y; Bouchon, B; Chavignon, O; Chezal, JM; Debiton, E; Desbois, N; Gardette, M; Labarre, P; Lartigue, C; Madelmont, JC; Maisonial, A; Maublant, J; Moins, N; Papon, J; Teulade, JC | 1 |
1 other study(ies) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and B16 Melanoma
Article | Year |
---|---|
Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.
Topics: Acridines; Animals; Antineoplastic Agents; Cell Survival; Drug Design; Humans; Inhibitory Concentration 50; Iodine Radioisotopes; Jurkat Cells; Magnetic Resonance Spectroscopy; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Radionuclide Imaging; Radiopharmaceuticals; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Tissue Distribution | 2008 |